Skip to main content

Table 4 CVD risk inicators at baseline, and changes during intervention

From: Effectiveness of a physical activity program on cardiovascular disease risk in adult primary health-care users: the “Pas-a-Pas” community intervention trial

 

Baseline

 

Changes during intervention (End - Baseline)

 
 

CG (n = 104)

IG (n = 260)

p

CG (n = 104)

IG (n = 260)

p

SBP (mmHg)

135.32 (16.62)

131.06 (15.94)

0.280

0.90 (18.63)

−3.59 (16.45)

0.029

DBP (mmHg)

75.96 (9.86)

76.75 (9.09)

0.478

−1.29 (10.64)

−3.03 (9.75)

0.140

Weight (Kg)

75.72 (14.92)

75.37 (14.80)

0.843

0.08 (4.52)

−1.23 (8.02)

0.151

BMI (Kg/m2)

29.95 (4.88)

30.01 (5.02)

0.924

−0.03 (1.91)

−0.22 (2.38)

0.471

WC (cm)

100.31 (11.74)

100.50 (11.81)

0.895

−1.58 (5.79)

−2.96 (8.99)

0.168

Total Cholesterol (mg/dL)

206.83 (32.67)

205.26 (36.58)

0.713

0.09 (32.96)

−10.68 (31.81)

0.006

HDL-cholesterol (mg/dL)

56.37 (16.09)

55.51 (14.86)

0.641

−1.18 (10.26)

−0.07 (12.37)

0.435

LDL-cholesterol (mg/dL)

122.70 (29.62)

122.33 (34.14)

0.922

1.82 (26.48)

−7.18 (29.04)

0.009

TG (mg/dL)

134.63 (83.91)

132.26 (67.75)

0.786

−3.11 (60.33)

−3.26 (60.26)

0.983

HbA1c (%)

7.21 (1.61)

7.40 (1.37)

0.599

−0.33 (1.42)

−0.08 (1.20)

0.476

Glucose (mg/dL)

99.19 (33.91)

98.66 (28.42)

0.883

−5.16 (21.04)

2.96 (19.45)

0.001

REGICOR

4.63 (3.54)

4.60 (3.97)

0.962

0.37 (2.53)

−0.28 (2.55)

0.064

Change from smoking to non-smoking

      

 Smoking (%)

4.20

7.90

0.123

1.00

0.90

0.369

  1. Values are expressed in mean and (standard deviation)
  2. CG Control group, IG Intervention group, SBP Systolic blood pressure, DBP Diastolic blood pressure, BMI Body mass index, WC Waist circumference, HDL High-density lipoprotein, LDL Low-density lipoprotein, TG Triglycerides, HbA1c Glycated hemoglobin; Cardiovascular disease risk REGICOR scale